SCHEMBL518397

SCHEMBL518397

[CH]1CNCCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL176488 0.94
SCHEMBL8372 0.80
SCHEMBL1783957 0.76
SCHEMBL23967576 0.71
SCHEMBL17734073 0.69 ALDH1A1 (0.40)
SCHEMBL9421 0.67
SCHEMBL519615 0.67
SCHEMBL574734 0.65 ALDH1A1 (0.33)
SCHEMBL21295283 0.62 ALDH1A1 (0.56)
SCHEMBL8857 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11566032-B2 Radio-protective and chemo-protective substituted thiols Tonix Pharmaceuticals, Inc. (US) 2023-01-31 US claimed
CN-113811521-B Process for producing fluorinated iodinated organic compounds 大金工业株式会社 2024-07-09 CN disclosed
US-20240197752-A1 SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY NEUPHARMA INC 2024-06-20 US disclosed
US-11945773-B2 Method for producing propionic acid derivative DAIKIN INDUSTRIES, LTD. (JP) 2024-04-02 US disclosed
US-11932596-B2 Fluorovinyl ether compound DAIKIN INDUSTRIES, LTD. (JP) 2024-03-19 US disclosed
WO-2024053502-A1 METHOD FOR PRODUCING α-CHLOROACRYLIC ACID ESTER ダイキン工業株式会社 2024-03-14 WO disclosed
CN-112004793-B Process for producing fluorinated organic compound 大金工业株式会社 2024-02-27 CN disclosed
WO-2024029525-A1 METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUND ダイキン工業株式会社 2024-02-08 WO disclosed
EP-4306506-A1 HALOETHER, METHOD FOR PRODUCING SAME, VINYL ETHER, AND METHOD FOR PRODUCING SAME Daikin Industries, Ltd. (JP) 2024-01-17 EP disclosed
US-11865120-B2 Substituted quinazolines for inhibiting kinase activity NEUPHARMA, INC. (US) 2024-01-09 US disclosed
US-20110112133-A1 DIHYDRO PYRROLOQUINOLINE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-05-12 US disclosed
WO-2011055810-A1 DIHYDRO PYRROLOQUINOLINE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-05-12 WO disclosed
EP-2298731-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2011-03-23 EP disclosed
WO-2010090737-A1 PYRIDAZINONE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-12 WO disclosed
US-20100197651-A1 Pyridazinone compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-05 US disclosed
WO-2010018874-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 WO disclosed
US-20100041891-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 US disclosed
US-20090156572-A1 Nitrogen-containing heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED 2009-06-18 US disclosed
WO-2009072643-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-11 WO disclosed
US-20070254877-A1 Indole Derivative and Use for Treatment of Cancer TAKADA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-11-01 US disclosed